Slow Start for New Alzheimer’s Drug Shown to Curb Cognitive Decline

Published on February 6, 2023

The race against Alzheimer’s has a new player: the first drug to show promise at slowing cognitive decline. But don’t get too excited just yet. We’ll have to wait a bit longer before most patients can access this groundbreaking treatment. Why the delay? Well, it seems that insurance coverage is being a bit of a party pooper, with limited support for the pricey medication. On top of that, many health systems require an extensive setup period before they can administer the drug effectively. It’s like planning a road trip but getting stuck in bumper-to-bumper traffic before you even leave your driveway. While some lucky patients might be able to jump into the fast lane, most will need to be patient. Let’s hope that insurance companies come on board and health systems streamline their processes, because we’re all cheering for this new treatment in the fight against Alzheimer’s! To learn more about this breakthrough drug and its potential impact, check out the underlying research.

The first drug to show that it slows Alzheimer’s is on sale, but treatment for most patients is still several months away. Two big factors behind the slow debut, experts say, are scant insurance coverage and a long setup time needed by many health systems. Patients who…

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>